These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 24285257

  • 1. Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis.
    Gomes Quinderé AL, Benevides NM, Carbone F, Mach F, Vuilleumier N, Montecucco F.
    Thromb Haemost; 2014 Apr 01; 111(4):634-46. PubMed ID: 24285257
    [Abstract] [Full Text] [Related]

  • 2. Chemokines in atherosclerosis: proceedings resumed.
    Zernecke A, Weber C.
    Arterioscler Thromb Vasc Biol; 2014 Apr 01; 34(4):742-50. PubMed ID: 24436368
    [Abstract] [Full Text] [Related]

  • 3. Multiple roles for neutrophils in atherosclerosis.
    Soehnlein O.
    Circ Res; 2012 Mar 16; 110(6):875-88. PubMed ID: 22427325
    [Abstract] [Full Text] [Related]

  • 4. Role of neutrophils in atherogenesis: an update.
    Pende A, Artom N, Bertolotto M, Montecucco F, Dallegri F.
    Eur J Clin Invest; 2016 Mar 16; 46(3):252-63. PubMed ID: 26573245
    [Abstract] [Full Text] [Related]

  • 5. Neutrophilic granulocytes - promiscuous accelerators of atherosclerosis.
    Drechsler M, Döring Y, Megens RT, Soehnlein O.
    Thromb Haemost; 2011 Nov 16; 106(5):839-48. PubMed ID: 22012406
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil's weapons in atherosclerosis.
    Chistiakov DA, Bobryshev YV, Orekhov AN.
    Exp Mol Pathol; 2015 Dec 16; 99(3):663-71. PubMed ID: 26551083
    [Abstract] [Full Text] [Related]

  • 7. Neutrophils in atherosclerosis: from mice to man.
    Döring Y, Drechsler M, Soehnlein O, Weber C.
    Arterioscler Thromb Vasc Biol; 2015 Feb 16; 35(2):288-95. PubMed ID: 25147339
    [Abstract] [Full Text] [Related]

  • 8. Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation.
    de Jager SC, Bot I, Kraaijeveld AO, Korporaal SJ, Bot M, van Santbrink PJ, van Berkel TJ, Kuiper J, Biessen EA.
    Arterioscler Thromb Vasc Biol; 2013 Mar 16; 33(3):e75-83. PubMed ID: 23288165
    [Abstract] [Full Text] [Related]

  • 9. Update on the role of neutrophils in atherosclerotic plaque vulnerability.
    Carbone F, Mach F, Montecucco F.
    Curr Drug Targets; 2015 Mar 16; 16(4):321-33. PubMed ID: 25382205
    [Abstract] [Full Text] [Related]

  • 10. Neutrophils in atherosclerosis. A brief overview.
    Hartwig H, Silvestre Roig C, Daemen M, Lutgens E, Soehnlein O.
    Hamostaseologie; 2015 Mar 16; 35(2):121-7. PubMed ID: 25385255
    [Abstract] [Full Text] [Related]

  • 11. Inflammation, C-reactive protein, and atherothrombosis.
    Ridker PM, Silvertown JD.
    J Periodontol; 2008 Aug 16; 79(8 Suppl):1544-51. PubMed ID: 18673009
    [Abstract] [Full Text] [Related]

  • 12. Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives.
    Baetta R, Corsini A.
    Atherosclerosis; 2010 May 16; 210(1):1-13. PubMed ID: 19931081
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.
    Goldfine AB, Shoelson SE.
    J Clin Invest; 2017 Jan 03; 127(1):83-93. PubMed ID: 28045401
    [Abstract] [Full Text] [Related]

  • 14. Targeting chemokine receptors in chronic inflammatory diseases: an extensive review.
    Koelink PJ, Overbeek SA, Braber S, de Kruijf P, Folkerts G, Smit MJ, Kraneveld AD.
    Pharmacol Ther; 2012 Jan 03; 133(1):1-18. PubMed ID: 21839114
    [Abstract] [Full Text] [Related]

  • 15. Role of neutrophils in different stages of atherosclerosis.
    Zhang X, Kang Z, Yin D, Gao J.
    Innate Immun; 2023 Aug 03; 29(6):97-109. PubMed ID: 37491844
    [Abstract] [Full Text] [Related]

  • 16. Inflammatory biomarkers of coronary atheromatous plaque vulnerability.
    Avanzas P, Arroyo-Espliguero R, Garcia-Moll X, Kaski JC.
    Panminerva Med; 2005 Jun 03; 47(2):81-91. PubMed ID: 16210993
    [Abstract] [Full Text] [Related]

  • 17. Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis.
    Little PJ, Chait A, Bobik A.
    Pharmacol Ther; 2011 Sep 03; 131(3):255-68. PubMed ID: 21510977
    [Abstract] [Full Text] [Related]

  • 18. Pathophysiological role of neutrophils in acute myocardial infarction.
    Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F.
    Thromb Haemost; 2013 Sep 03; 110(3):501-14. PubMed ID: 23740239
    [Abstract] [Full Text] [Related]

  • 19. Blockade of CXCR2 signalling: a potential therapeutic target for preventing neutrophil-mediated inflammatory diseases.
    Boppana NB, Devarajan A, Gopal K, Barathan M, Bakar SA, Shankar EM, Ebrahim AS, Farooq SM.
    Exp Biol Med (Maywood); 2014 May 03; 239(5):509-18. PubMed ID: 24625439
    [Abstract] [Full Text] [Related]

  • 20. Chemokines in atherosclerosis: an update.
    Zernecke A, Shagdarsuren E, Weber C.
    Arterioscler Thromb Vasc Biol; 2008 Nov 03; 28(11):1897-908. PubMed ID: 18566299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.